Dorzolamide Hydrochloride And Timolol Maleate Solution
Product Images NDC 61314-030

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride And Timolol Maleate (NDC 61314-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructuredorzol (Image 01)

FDA Label Image

Chemicalstructuretimolol (Image 01a)

FDA Label Image

Shake (Image 02)

FDA Label Image

Invert (Image 03)

FDA Label Image

Tilt (Image 04)

FDA Label Image

Eye (Image 05)

FDA Label Image

Drop (Image 06)

FDA Label Image

Carton (Image 07)

Carton (Image 07)
This is information on a prescription medication in the form of an ophthalmic solution for topical application in the eye. The solution contains Dorzolamide HCl and Timolol Maleate in specific percentages per mL. Each mL contains 22.3 mg of Dorzolamide and 6.8 mg of Timolol. The solution is sterile and is manufactured by Alcon Laboratories in Fort Worth, Texas, and marketed by Sandoz Inc. The usual dosage and storage information are included, along with warnings about protecting it from light and preventing contamination.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.